SeqOnce Biosciences
Latest round
- Seed
Last raised
- May 2018
Total raised
- $1.2M
Investors
- 3
About SeqOnce Biosciences
Founded in 2014 and headquartered in Pasadena, US, SeqOnce Biosciences specializes in genomic research solutions. The company was co-founded by Chris Angermayer, who has a history of founding other biotech ventures.SeqOnce Biosciences specializes in developing advanced assays and reagents aimed at enhancing genomic research and diagnostic capabilities. Their offerings include high-quality qPCR assays and next-generation sequencing (NGS) products for rapid pathogen nucleic acid detection. Notable products include the H5N1 Avian Influenza Panel and various microbiota panels, intended for use by researchers, clinical laboratories, and conservationists.SeqOnce generates revenue through direct sales of its assays and reagents to clients in the scientific and medical research sectors. Transactions are typically conducted on a B2B basis, with products sold either as one-time orders or through recurring procurement agreements for ongoing projects. The pricing structure reflects the specialized nature of their offerings, with flagship products such as the SeqOnce Amplification Master Mixes being pivotal to the company's revenue model. The company is focused on designing additional pathogen detection panels and enhancing its qPCR assays, with new products expected to be launched by late 2019. Furthermore, SeqOnce aims to expand its presence in Asia and Europe by 2020.
Who invested in SeqOnce Biosciences
3 investors across 1 round
See all investors in SeqOnce Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 8, 2018
Amount
$1.2M
Investors
Questions about SeqOnce Biosciences
Who invested in SeqOnce Biosciences?
SeqOnce Biosciences has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SeqOnce Biosciences raised?
SeqOnce Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SeqOnce Biosciences last raise money?
SeqOnce Biosciences's most recent round on record is a Seed, in May 2018.
What does SeqOnce Biosciences do?
Founded in 2014 and headquartered in Pasadena, US, SeqOnce Biosciences specializes in genomic research solutions.
Where is SeqOnce Biosciences headquartered?
SeqOnce Biosciences is headquartered in Pasadena, US.
Which VCs invest in companies like SeqOnce Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at SeqOnce Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like SeqOnce Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.